These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 17602094)
1. Sunitinib malate and multiple receptor tyrosine kinases inhibitors: are they also novel drugs for chronic and neurophatic pain? Di Lorenzo L J Clin Oncol; 2007 Jul; 25(19):2858-9; author reply 2859-61. PubMed ID: 17602094 [No Abstract] [Full Text] [Related]
11. CCR drug updates: sorafenib and sunitinib in renal cell carcinoma. Stein MN; Flaherty KT Clin Cancer Res; 2007 Jul; 13(13):3765-70. PubMed ID: 17606705 [No Abstract] [Full Text] [Related]
12. The emerging role of sunitinib in the treatment of advanced epithelial thyroid cancer: our experience and review of literature. Pasqualetti G; Ricci S; Dardano A; Ferdeghini M; Del Tacca M; Monzani F Mini Rev Med Chem; 2011 Aug; 11(9):746-52. PubMed ID: 21707530 [TBL] [Abstract][Full Text] [Related]
13. Sorafenib and sunitinib in the treatment of advanced non-small cell lung cancer. Gridelli C; Maione P; Del Gaizo F; Colantuoni G; Guerriero C; Ferrara C; Nicolella D; Comunale D; De Vita A; Rossi A Oncologist; 2007 Feb; 12(2):191-200. PubMed ID: 17296815 [TBL] [Abstract][Full Text] [Related]
14. The oral tyrosine kinase inhibitors lapatinib and sunitinib: new opportunities for the treatment of brain metastases from breast cancer? Addeo R; Caraglia M Expert Rev Anticancer Ther; 2011 Feb; 11(2):139-42. PubMed ID: 21342029 [No Abstract] [Full Text] [Related]
15. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors. Faivre S; Djelloul S; Raymond E Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796 [TBL] [Abstract][Full Text] [Related]
16. The discovery and development of SU14813, a next-generation multitargeted tyrosine kinase inhibitor for the treatment of human malignancies. Hu-Lowe D; Brega N; Patyna S Mol Cancer Ther; 2011 Nov; 10(11):2015. PubMed ID: 22072801 [No Abstract] [Full Text] [Related]
17. Artificial signal transduction therapy: a futuristic approach to disease treatment. Peri-Naor R; Motiei L; Margulies D Future Med Chem; 2015; 7(16):2091-3. PubMed ID: 26510968 [No Abstract] [Full Text] [Related]
18. SU11248 and AG013736: current data and future trials in renal cell carcinoma. Rini BI Clin Genitourin Cancer; 2005 Dec; 4(3):175-80. PubMed ID: 16425985 [TBL] [Abstract][Full Text] [Related]